{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T00:40:34Z","timestamp":1791679234135,"version":"4.3.4"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Coronavirus disease 2019 (COVID-19)\u2013associated pulmonary aspergillosis (CAPA) is a life-threatening fungal infection. Studies focusing on CAPA in low- and middle-income countries are limited.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This retrospective matched case-control study was conducted at a tertiary care center in South India. Cases of CAPA were classified using the 2020 European Confederation of Medical Mycology\/International Society for Human and Animal Mycology consensus criteria. A total of 95 cases were matched 1:1 with COVID-19 patients without CAPA. Matching was done based on age and period of admission. Inverse probability weighting was used to account for imbalances in COVID-19 severity and intensive care unit (ICU) admission. Data on demographics, clinical details, microbiologic and radiologic data, and treatment outcomes were collected. A predictive score for CAPA was developed from baseline risk factors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The predictive score identified lymphopenia, European Organisation for Research and Treatment of Cancer risk factors, and broad-spectrum antibiotic use as the main risk factors for CAPA. Positivity for bacterial pathogens in blood or bronchoalveolar lavage samples reduced the risk of CAPA. The predictive model performed well in cross-validation, with an area under the curve value of 82%. CAPA diagnosis significantly increased mortality and shift to ICU.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The predictive model derived from the current study offers a valuable tool for clinicians, especially in high-endemic low- and middle-income countries, for the early identification and treatment of CAPA. With further validation, this risk score could improve patient outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofae406","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T12:16:56Z","timestamp":1721737016000},"source":"Crossref","is-referenced-by-count":4,"title":["Predicting COVID 19\u2013Associated Pulmonary Aspergillosis Risk in Low- and Middle-Income Countries: A Matched Case-Control Study"],"prefix":"10.1093","volume":"11","author":[{"given":"Merlin","family":"Moni","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1098-9900","authenticated-orcid":false,"given":"Dipu T","family":"Sathyapalan","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabia","family":"Edathadathil","sequence":"additional","affiliation":[{"name":"Department of Infection Control and Epidemiology, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Abdul","family":"Razak","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivapriya G","family":"Nair","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chithira V","family":"Nair","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swathy S","family":"Samban","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetha","family":"Prasanna","sequence":"additional","affiliation":[{"name":"Department of Medical Administration, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran G","family":"Kulirankal","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of General Medicine, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam Sundar","family":"Purushothaman","sequence":"additional","affiliation":[{"name":"Department of Anaesthesiology and Critical Care, Amrita Institute of Medical Science and Research Centre, Amrita Vishwa Vidyapeetham , Kochi, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Gutjahr","sequence":"additional","affiliation":[{"name":"Center for Research in Analytics and Technology for Education, Amrita Vishwa Vidyapeetham , Kollam, Kerala , India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Ying","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teny M","family":"John","sequence":"additional","affiliation":[{"name":"Division of Internal Medicine, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center , Houston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,7,23]]},"reference":[{"key":"2024072611060209400_ofae406-B1","author":"World Health Organization"},{"key":"2024072611060209400_ofae406-B2","doi-asserted-by":"crossref","first-page":"2002554","DOI":"10.1183\/13993003.02554-2020","article-title":"Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis","volume":"56","author":"Armstrong-James","year":"2020","journal-title":"Eur Respir J"},{"key":"2024072611060209400_ofae406-B3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jointm.2021.07.001","article-title":"COVID-19\u2013associated pulmonary aspergillosis (CAPA)","volume":"1","author":"Dimopoulos","year":"2021","journal-title":"J Intensive Med"},{"key":"2024072611060209400_ofae406-B4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/thorax-2023-220002","article-title":"COVID-19\u2013associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study","volume":"79","author":"Hurt","year":"2023","journal-title":"Thorax"},{"key":"2024072611060209400_ofae406-B5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.cmi.2021.06.025","article-title":"COVID-19\u2013associated pulmonary aspergillosis (CAPA): how big a problem is it?","volume":"27","author":"Fekkar","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2024072611060209400_ofae406-B6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/myc.13434","article-title":"COVID-19\u2013associated pulmonary aspergillosis (CAPA): risk factors and development of a predictive score for critically ill COVID-19 patients","volume":"65","author":"Calder\u00f3n-Parra","year":"2022","journal-title":"Mycoses"},{"key":"2024072611060209400_ofae406-B7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3390\/jof9010081","article-title":"COVID-19\u2013associated pulmonary aspergillosis (CAPA) in northern Greece during 2020\u20132022: a comparative study according to the main consensus criteria and definitions","volume":"9","author":"Siasios","year":"2023","journal-title":"J Fungi (Basel)"},{"key":"2024072611060209400_ofae406-B8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA)\u2014from immunology to treatment","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J Fungi (Basel)"},{"key":"2024072611060209400_ofae406-B9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/cid\/ciad546","article-title":"High burden of COVID-19\u2013associated pulmonary aspergillosis in severely immunocompromised patients requiring mechanical ventilation","volume":"78","author":"Feys","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2024072611060209400_ofae406-B10","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19\u2013associated pulmonary aspergillosis: the 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2024072611060209400_ofae406-B11","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.5005\/jp-journals-10071-24314","article-title":"Covid-19\u2013associated pulmonary aspergillosis: a case series","volume":"26","author":"Sharma","year":"2022","journal-title":"Indian J Crit Care Med"},{"key":"2024072611060209400_ofae406-B12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.cmi.2023.12.006","article-title":"Risk factors, mortality, and predictors of survival in COVID-19\u2013associated pulmonary mucormycosis: a multicenter retrospective study from India","volume":"30","author":"Muthu","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"2024072611060209400_ofae406-B13","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/s41564-022-01172-2","article-title":"COVID-19\u2013associated fungal infections","volume":"7","author":"Hoenigl","year":"2022","journal-title":"Nat Microbiol"},{"key":"2024072611060209400_ofae406-B14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/myc.13183","article-title":"Bronchoscopy safety precautions for diagnosing COVID-19 associated pulmonary aspergillosis\u2014a simulation study","volume":"64","author":"Koehler","year":"2021","journal-title":"Mycoses"},{"key":"2024072611060209400_ofae406-B15","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00134-021-06510-2","article-title":"COVID-19 associated pulmonary aspergillosis: regional variation in incidence and diagnostic challenges","volume":"47","author":"Prattes","year":"2021","journal-title":"Intensive Care Med"},{"key":"2024072611060209400_ofae406-B16","author":"Indian SARS-CoV-2 Genomics Consortium"},{"key":"2024072611060209400_ofae406-B17","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","article-title":"Regression shrinkage and selection via the lasso","volume":"58","author":"Tibshirani","year":"1996","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"2024072611060209400_ofae406-B18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"2024072611060209400_ofae406-B19","doi-asserted-by":"crossref","first-page":"ofae082","DOI":"10.1093\/ofid\/ofae082","article-title":"Modeling invasive aspergillosis risk for the application of prophylaxis strategies","volume":"11","author":"Young","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"2024072611060209400_ofae406-B20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12879-024-09283-3","article-title":"Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit","volume":"24","author":"Iacovelli","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2024072611060209400_ofae406-B21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jinf.2019.04.002","article-title":"Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies","volume":"78","author":"Stanzani","year":"2019","journal-title":"J Infect"},{"key":"2024072611060209400_ofae406-B22","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.2174\/1381612811319200010","article-title":"Immunotherapy in invasive fungal infection\u2014focus on invasive aspergillosis","volume":"19","author":"Lehrnbecher","year":"2013","journal-title":"Curr Pharm Des"},{"key":"2024072611060209400_ofae406-B23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13613-017-0242-0","article-title":"Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission","volume":"7","author":"Adrie","year":"2017","journal-title":"Ann Intensive Care"},{"key":"2024072611060209400_ofae406-B24","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.3390\/v12111277","article-title":"CD4 and CD8 lymphocyte counts as surrogate early markers for progression in SARS-CoV-2 pneumonia: a prospective study","volume":"12","author":"Calvet","year":"2020","journal-title":"Viruses"},{"key":"2024072611060209400_ofae406-B25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3855\/jidc.14404","article-title":"Use of antibiotics in COVID-19 ICU patients","volume":"15","author":"Mustafa","year":"2021","journal-title":"J Infect Dev Ctries"},{"key":"2024072611060209400_ofae406-B26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jiph.2021.02.001","article-title":"Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy","volume":"14","author":"Chedid","year":"2021","journal-title":"J Infect Public Health"},{"key":"2024072611060209400_ofae406-B27","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/s41467-021-22845-2","article-title":"A peptidoglycan storm caused by \u03b2-lactam antibiotic's action on host microbiota drives Candida albicans infection","volume":"12","author":"Tan","year":"2021","journal-title":"Nat Commun"},{"key":"2024072611060209400_ofae406-B28","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.155.4.9105054","article-title":"Biological markers of acute lung injury: prognostic and pathogenetic significance","volume":"155","author":"Pittet","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"2024072611060209400_ofae406-B29","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.cmi.2021.02.021","article-title":"Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study","volume":"27","author":"Danion","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2024072611060209400_ofae406-B30","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","article-title":"Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study","volume":"27","author":"Garcia-Vidal","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2024072611060209400_ofae406-B31","first-page":"1","article-title":"The role of co-infections and secondary infections in patients with COVID-19","volume":"13","author":"Feldman","year":"2021","journal-title":"Pneumonia (Nathan)"},{"key":"2024072611060209400_ofae406-B32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13054-022-03902-8","article-title":"Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients","volume":"26","author":"Leistner","year":"2022","journal-title":"Crit Care"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofae406\/58563904\/ofae406.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/7\/ofae406\/58656922\/ofae406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/11\/7\/ofae406\/58656922\/ofae406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T11:07:53Z","timestamp":1721992073000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofae406\/7715563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,6,28]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofae406","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,7]]},"published":{"date-parts":[[2024,6,28]]},"article-number":"ofae406"}}